Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL709074

Cn1ccnc1COc1cc(OCCc2ccc(F)cc2)cc(-c2nc3cccnc3[nH]2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.36
HCAR2 Q8TDS4 1/20 0.34
THRB P10828 1/20 0.34
CACNA1B Q00975 3/20 0.33
ALOX5AP P20292 2/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
NOS1 P29475 1/20 0.33
PRCP P42785 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MMP13 P45452 1/20 0.32
ENPP2 Q13822 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL718789 0.95 PDE4A (0.35) NAMPTKDM4EMEN1KMT2ASYK
Trifluoroacetic Acid SCHEMBL711960 0.94 LMNA (0.37) HCAR2THRBCASP3SENP8SENP6
Trifluoroacetic Acid SCHEMBL713293 0.93 MEN1 (0.36) NAMPTHCAR2CACNA1BCASP3SENP8
SCHEMBL10206670 0.93 NPC1 (0.35) NAMPTHCAR2THRBCASP3SENP8
Trifluoroacetic Acid SCHEMBL711889 0.92 HDAC3 (0.34) MMP13SYK
Trifluoroacetic Acid SCHEMBL709575 0.90 SYK (0.34) NAMPTCASP3SENP8SENP6NOS1
Trifluoroacetic Acid SCHEMBL712600 0.89 FAAH (0.38) ALOX5APNOS1SYK
Trifluoroacetic Acid SCHEMBL711504 0.88 NOS1 (0.35) NOS1KDM4EMAPTMEN1KMT2A
SCHEMBL10206669 0.88 MEN1 (0.35) THRBMAPTMEN1KMT2ATP53
Trifluoroacetic Acid SCHEMBL708256 0.87 GUCY1B2 (0.36) CASP3SENP8SENP6KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK NAMPT 148/4885HCAR2 2738/4885THRB 2521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.